Ferumoxytol (Feraheme) - A new parenteral iron formulation

Medical Letter on Drugs and Therapeutics

Volumn 52, Issue 1334, 2010, Pages 23-

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

FERAHEME; FERRIC GLUCONATE; FERRIC HYDROXIDE SUCROSE; FERROUS FUMARATE; FERUMOXYTOL; IRON DEXTRAN; PLACEBO; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONSTIPATION; DIALYSIS; DIARRHEA; DIZZINESS; DRUG ABSORPTION; DRUG APPROVAL; DRUG COST; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL ABSORPTION; HUMAN; HYPERSENSITIVITY REACTION; HYPOTENSION; IRON DEFICIENCY ANEMIA; NAUSEA; PERIPHERAL EDEMA; PRURITUS; RASH; WHEEZING;

ANAPHYLAXIS; ANEMIA, APLASTIC; CHEMISTRY, PHARMACEUTICAL; FERROSOFERRIC OXIDE; HUMANS; INFUSIONS, PARENTERAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77950441070     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. M Auerbach. Ferumoxytol as a new, safer, easier-to-administer intravenous iron: yes or no? Am J Kidney Dis 2008; 52:826.
2. R Provenzano et al. Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients. Clin J Am Soc Nephrol 2009; 4:386.
3. BS Spinowitz et al. Ferumoxytol for treating iron deficiency anemia in CKD. J Am Soc Nephrol 2008; 19:1599.
4. A Singh et al. Safety of ferumoxytol in patients with anemia and CKD. Am J Kidney Dis 2008; 52:907.
5. Price according to AWP listings in Red Book 2009 or Update, March 2010.